Arcutis Biotherapeutics financial statements
아커티스 바이오테라퓨틱스NASDAQ:ARQT · Nasdaq · Healthcare · sector #17$23.92-4.89%
2026-10-06 closeArcutis Biotherapeutics's published financial data is dated 2026-10-04. 2024 revenue was $197M. 2024 operating profit was −$128M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy